Cannabis News

Canna Law Blog

• When Loans Go Wrong: Washington Cannabis Property Foreclosures August 4, 2021
  It is difficult to talk about Washington cannabis grows without considering real estate issues for the many companies and individuals that lend or want to lend funds to cannabis businesses. As indoor cannabis growing facilities sprout throughout Washington state, a growing issue for both private and institutional lenders is which method of foreclosure to pursue […]
• Cannabis Litigation: The New-ish Trend in TCPA Claims After Facebook August 3, 2021
  In April, we wrote about the Facebook v. Duguid ruling issued by the Supreme Court was likely going to gut a great number of TCPA cases pending across the United States, some of which involve cannabis companies. As a quick recap, the Supreme Court had narrowed the definition of the “automatic telephone dialing system” (“ATDS”) […]
• Washington Cannabis: LCB Bans Conversion of CBD into Delta-9 THC August 2, 2021
  On July 22, the Washington State Liquor and Cannabis Board (“LCB”) issued a notice of adoption of an interpretive statement (the “Notice”) in which the agency clarified authorized practices for marijuana processor licensees. The Notice stipulates that licensed marijuana processors cannot legally convert cannabidiol (“CBD”) into delta-9 THC because their license privileges do not allow […]
• New York Cannabis: Lawyers Can Consume, Advise Businesses and Own Them (if They Dare) August 1, 2021
  In the continuing trend of normalizing the cannabis industry for practical reasons (a topic I will be discussing with New York City Council Member Keith Powers on August 17 at this free webinar), the New York State Bar Association’s (NYSBA) Committee on Professional Ethics issued Opinion 1225 (the Opinion). In short, the NYSBA now expressly […]
• Cannabis M&A: Get to Know Your New Landlord July 31, 2021
  Getting to closing on a cannabis M&A transaction is always a hurdle (read about that process in detail here). There are always a lot more contingencies to closing for cannabis M&A transactions than for run-of-the-mill businesses that don’t operate in highly regulated fields (e.g., cannabis acquisitions will require approval from state and possibly local agencies). […]
• Elections and Cannabis in Germany: Green All Around July 30, 2021
  Germany will hold parliamentary elections on September 26 of this year. While the ruling Union is expected to win the largest number of seats in the Bundestag, the majority of polls show the Greens (officially Alliance 90/The Greens) taking the second-highest number of seats. In fact, as recently as May, some polls had die Grünen […]
• Oregon’s New “THC in Milligrams” Limit July 29, 2021
  Earlier this month, Oregon Governor Kate Brown signed into law HB 3000, an omnibus bill covering a wide range of hemp-related issues. Unlike other cannabis bills passed last session, HB 3000 was written to take effect on passage, so it is now law. One of the important HB 3000 terms is a restriction on the sale […]
• Oregon Psilocybin: Advisory Board and Licensing Update July 28, 2021
  On March 18, Governor Kate Brown appointed members to the Oregon Psilocybin Advisory Board, which held its first meeting on March 31. Since then, the Board has met monthly and created five subcommittees to study facets of the emerging psilocybin industry including research, equity, manufacturing, training, and licensing. I chair the Licensing Subcommittee, which focuses […]
• FY22 Agriculture Appropriation Bill: A Good Omen for the Hemp Industry July 27, 2021
  On June 29, the House Appropriations Committee (the Committee) released the draft of the fiscal year 2022 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies funding bill (the FY22 Agriculture Appropriations Bill), along with its Committee Report, in which it offers some promising provisions and instructions that would greatly benefit the hemp industry. […]
• California Ketamine Clinics: Implications From Epic Medical Management, LLC v. Paquette July 26, 2021
  The corporate practice of medicine doctrine (“CPOM”) and state anti-kickback prohibitions vary from state to state. While some states have statutory prohibitions, other states rely upon case law for CPOM. These issues are typically not heavily litigated. When there is case law covering these subjects, it is imperative to review and understand these decisions. They […]

Read full feed